Michael Bernard Vaughan

Michael Bernard Vaughan

Auto-generated profile, based on publicly available information

Michael Bernard Vaughan

Center for Medical Genetics Ghent, Ghent University Hospital, Ghent, Belgium

Research Focus & Metrics

Academic Career Length

3Years (2024-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
11 June 2024 in Nature Communications
Verified
Journal Article
Open access
PDF file
KSKeith Siew
Keith Siew
KNKevin A Nestler
Kevin A Nestler
CNCharlotte Nelson
Charlotte Nelson
VDViola D'Ambrosio
Viola D'Ambrosio
CZChutong Zhong
Chutong Zhong
SWStephen B Walsh
Stephen B Walsh
Missions into Deep Space are planned this decade. Yet the health consequences of exposure to microgravity and galactic cosmic radiation (GCR) over years-long missions on indispensable visceral organs such as the kidney are largely unexplored. We performed biomolecular (epigenomic, transcriptomic, proteomic, epiproteomic, metabolomic, metagenomic), clinical chemistry (electrolytes, endocrinology, biochemistry) and morphometry (histology, 3D imaging, miRNA-ISH, tissue weights) analyses using samples and datasets available from 11 spaceflight-exposed mouse and 5 human, 1 simulated microgravity rat and 4 simulated GCR-exposed mouse missions. We found that spaceflight induces: 1) renal transporter dephosphorylation which may indicate astronauts’ increased risk of nephrolithiasis is in part a primary renal phenomenon rather than solely a secondary consequence of bone loss; 2) remodelling of the nephron that results in expansion of distal convoluted tubule size but loss of overall tubule density; 3) renal damage and dysfunction when exposed to a Mars roundtrip dose-equivalent of simulated GCR.

11 March 2025 in medRxiv
Verified
Preprint
Open access
PDF file
LHLisa Hamerlinck
Lisa Hamerlinck
EDEva D’haene
Eva D’haene
NLNore Van Loon
Nore Van Loon
MVMichael B Vaughan
Michael B Vaughan
María del Rocío Pérez BacaMaría del Rocío Pérez Baca
María del Rocío Pérez Baca
SVSarah Vergult
Sarah Vergult
The FOXG1 transcription factor is a crucial regulator of embryonic brain development. Pathogenic FOXG1 variants cause FOXG1 syndrome. Although structural variants (SVs) in the non-coding region downstream of FOXG1 have been reported in 38 individuals with similar characteristics, the regulatory pathomechanisms remain unknown. We identified a de novo non-coding deletion in an individual with FOXG1 syndrome-like disorder, allowing us to delineate a ∼124 kb commonly affected regulatory region (CARR). By integrating epigenomics data, 3D chromatin interaction profiles (Hi-C, UMI-4C), and in vivo enhancer assays in zebrafish, we uncovered multiple regulatory elements within this CARR, including a neuronal enhancer cluster and a conserved boundary of the FOXG1 -containing topologically associating domain (TAD). Hi-C analysis on case lymphoblastoid cells revealed increased interactions with the adjacent TAD. Moreover, sequential UMI-4C and CUT&RUN assays during neural progenitor cell (NPC) differentiation demonstrated dynamic activation of, and interaction with the enhancer cluster. Finally, CRISPR-Cas9 deletion of the enhancer cluster and TAD boundary in NPCs resulted in decreased FOXG1 transcription. We identified and characterized enhancer and architectural elements essential for proper FOXG1 transcription. Our findings provide new insights into chromatin architecture and gene regulation at the FOXG1 locus, improving SV interpretation in individuals with FOXG1 syndrome-like disorder.

3 June 2026 in Nature Communications
Verified
Journal Article
Open access
LHLisa Hamerlinck
Lisa Hamerlinck
EDEva D’HAene
Eva D’HAene
MVMichael B. Vaughan
Michael B. Vaughan
NLNore Van Loon
Nore Van Loon
María del Rocío Pérez BacaMaría del Rocío Pérez Baca
María del Rocío Pérez Baca
SVSarah Vergult
Sarah Vergult
The FOXG1 transcription factor is a crucial regulator of embryonic brain development. Pathogenic FOXG1 variants cause FOXG1 syndrome. Although structural variants in the non-coding region downstream of FOXG1 have been reported in 38 individuals with similar characteristics, the regulatory pathomechanisms remain unknown. Here, we identify two non-coding structural variants in individuals with FOXG1 syndrome-like features, allowing us to delineate a ~ 124 kb commonly affected regulatory region. Using epigenomic profiling and in vivo enhancer assays, we characterize and validate regulatory elements within the commonly affected regulatory region and wider FOXG1 TAD. We see strong activation of previously validated forebrain enhancers, and identify an enhancer cluster and progenitor-specific enhancer region that are strongly activated during forebrain-directed neural progenitor cell differentiation, a process in which FOXG1 is an important regulator. Perturbation of these elements results in varying degrees of reduced FOXG1 transcription in forebrain neural progenitor cells and in population shifts within these cells, while removal of the TAD boundary leads to aberrant expression of the neighbouring PRKD1 gene. Our findings characterize enhancer and architectural elements essential for proper FOXG1 transcription during neurodevelopment, therefore improving variant interpretation in this region.

11 November 2026 in STAR Protocols
Verified
Journal Article
Open access
LHLisa Hamerlinck
Lisa Hamerlinck
María del Rocío Pérez BacaMaría del Rocío Pérez Baca
María del Rocío Pérez Baca
NLNore Van Loon
Nore Van Loon
LVLies Vantomme
Lies Vantomme
EDEsperanza Daal
Esperanza Daal
SVSarah Vergult
Sarah Vergult

9 January 2025 in medRxiv
Verified
Preprint
Open access
PDF file
MVMichael Bernard Vaughan
Michael Bernard Vaughan
DBDante Joseph Bellai
Dante Joseph Bellai
MRMark G Rae
Mark G Rae
: There is a growing interest in the potential role that lifelong chronic viral infections may play in the aetiology of certain neurodegenerative diseases. For example, the disruption of neuronal intracellular trafficking by repeated reactivations of latent herpes viruses has been proposed as a possible inductive agent of Alzheimer’s disease (AD). This systematic review examines the extent of primary data that have examined the effect(s) of herpes viruses on the human intraneuronal trafficking (HINT) system. Three databases (MEDLINE, SCOPUS, and Web of Science), were repeatedly searched. 5782 articles were identified, of which 13 met our eligibility criteria, and five were included for qualitative synthesis. Four of the five collated studies presented data from cell culture experiments, wherein herpes simplex virus 1 (HSV-1) altered lysosomal load, lysosomal function, and activity-regulated cytoskeleton-associated protein (ARC) mRNA/protein expression in a cell-type/species specific manner. One of the five studies was a clinical case study that presented observations on a fatal herpes encephalopathy, wherein the neuronal endoplasmic reticulum and Golgi apparatus were ablated by the rampant infection. Unfortunately, there is an extremely limited amount of primary research examining the effects of herpes viruses on the HINT system, but within that limited pool there is clear evidence of cell type-/stage- specific responses to infection. Future studies investigating herpes infection in neurodegenerative disease need to utilise cell-type and species- specific models if they are to have any hope of extrapolating to a clinical setting.